These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24270663)

  • 1. Longitudinal study of recurrent metastatic melanoma cell lines underscores the individuality of cancer biology.
    Pos Z; Spivey TL; Liu H; Sommariva M; Chen J; Wunderlich JR; Parisi G; Tomei S; Ayotte BD; Stroncek DF; Malek JA; Robbins PF; Rivoltini L; Maio M; Chouchane L; Wang E; Marincola FM
    J Invest Dermatol; 2014 May; 134(5):1389-1396. PubMed ID: 24270663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonal persistence and evolution during a decade of recurrent melanoma.
    Wang E; Voiculescu S; Le Poole IC; El-Gamil M; Li X; Sabatino M; Robbins PF; Nickoloff BJ; Marincola FM
    J Invest Dermatol; 2006 Jun; 126(6):1372-7. PubMed ID: 16470173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and genetic diversity in the metastatic process of melanoma.
    Harbst K; Lauss M; Cirenajwis H; Winter C; Howlin J; Törngren T; Kvist A; Nodin B; Olsson E; Häkkinen J; Jirström K; Staaf J; Lundgren L; Olsson H; Ingvar C; Gruvberger-Saal SK; Saal LH; Jönsson G
    J Pathol; 2014 May; 233(1):39-50. PubMed ID: 24399611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple metastases from cutaneous malignant melanoma patients may display heterogeneous genomic and epigenomic patterns.
    Harbst K; Staaf J; Måsbäck A; Olsson H; Ingvar C; Vallon-Christersson J; Ringnér M; Borg A; Jönsson G
    Melanoma Res; 2010 Oct; 20(5):381-91. PubMed ID: 20848731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary dermal melanoma: a unique subtype of melanoma to be distinguished from cutaneous metastatic melanoma: a clinical, histologic, and gene expression-profiling study.
    Sidiropoulos M; Obregon R; Cooper C; Sholl LM; Guitart J; Gerami P
    J Am Acad Dermatol; 2014 Dec; 71(6):1083-92. PubMed ID: 25262174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conservation of genetic alterations in recurrent melanoma supports the melanoma stem cell hypothesis.
    Sabatino M; Zhao Y; Voiculescu S; Monaco A; Robbins P; Karai L; Nickoloff BJ; Maio M; Selleri S; Marincola FM; Wang E
    Cancer Res; 2008 Jan; 68(1):122-31. PubMed ID: 18172304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrative genome comparison of primary and metastatic melanomas.
    Kabbarah O; Nogueira C; Feng B; Nazarian RM; Bosenberg M; Wu M; Scott KL; Kwong LN; Xiao Y; Cordon-Cardo C; Granter SR; Ramaswamy S; Golub T; Duncan LM; Wagner SN; Brennan C; Chin L
    PLoS One; 2010 May; 5(5):e10770. PubMed ID: 20520718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene signature of the metastatic potential of cutaneous melanoma: too much for too little?
    Tímár J; Gyorffy B; Rásó E
    Clin Exp Metastasis; 2010 Aug; 27(6):371-87. PubMed ID: 20177751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoallelic expression in melanoma.
    Silcock L; Almabrazi H; Mokrab Y; Jithesh P; Al-Hashmi M; James N; Mathew R; Mattei V; Bedognetti D; Lessi F; Temanni R; Seliger B; Al-Ali R; Marincola FM; Wang E; Tomei S
    J Transl Med; 2019 Apr; 17(1):112. PubMed ID: 30953523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of KIT expression and gene mutation in human acral melanoma: with a comparison between primary tumors and corresponding metastases/recurrences.
    Dai B; Cai X; Kong YY; Yang F; Shen XX; Wang LW; Kong JC
    Hum Pathol; 2013 Aug; 44(8):1472-8. PubMed ID: 23528861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA copy number changes in tumors within the spectrum of cellular, atypical, and metastasizing fibrous histiocytoma.
    Charli-Joseph Y; Saggini A; Doyle LA; Fletcher CD; Weier J; Mirza S; Vemula S; LeBoit PE
    J Am Acad Dermatol; 2014 Aug; 71(2):256-63. PubMed ID: 24755122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative genomics reveals that loss of lunatic fringe (LFNG) promotes melanoma metastasis.
    Del Castillo Velasco-Herrera M; van der Weyden L; Nsengimana J; Speak AO; Sjöberg MK; Bishop DT; Jönsson G; Newton-Bishop J; Adams DJ
    Mol Oncol; 2018 Feb; 12(2):239-255. PubMed ID: 29193607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanoma progression.
    Elder DE
    Pathology; 2016 Feb; 48(2):147-54. PubMed ID: 27020387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of genetic disparity between primary and metastatic melanoma in human patients.
    Swoboda A; Rasin-Streden D; Schanab O; Okamoto I; Pehamberger H; Petzelbauer P; Mikula M
    Genes Chromosomes Cancer; 2011 Sep; 50(9):680-8. PubMed ID: 21584902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic profiling of invasive melanoma cell lines by array comparative genomic hybridization.
    Koroknai V; Ecsedi S; Vízkeleti L; Kiss T; Szász I; Lukács A; Papp O; Ádány R; Balázs M
    Melanoma Res; 2016 Apr; 26(2):100-7. PubMed ID: 26656572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Network assessment of demethylation treatment in melanoma: Differential transcriptome-methylome and antigen profile signatures.
    Jiang Z; Cinti C; Taranta M; Mattioli E; Schena E; Singh S; Khurana R; Lattanzi G; Tsinoremas NF; Capobianco E
    PLoS One; 2018; 13(11):e0206686. PubMed ID: 30485296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer/testis genes expression in human melanoma cell lines.
    Mikhaylova IN; Kovalevsky DA; Morozova LF; Golubeva VA; Cheremushkin EA; Lukashina MI; Voronina ES; Burova OS; Utyashev IA; Kiselev SL; Demidov LV; Beabealashvilli RSh; Baryshnikov AY
    Melanoma Res; 2008 Oct; 18(5):303-13. PubMed ID: 18781128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Network-guided analysis of genes with altered somatic copy number and gene expression reveals pathways commonly perturbed in metastatic melanoma.
    Valsesia A; Rimoldi D; Martinet D; Ibberson M; Benaglio P; Quadroni M; Waridel P; Gaillard M; Pidoux M; Rapin B; Rivolta C; Xenarios I; Simpson AJ; Antonarakis SE; Beckmann JS; Jongeneel CV; Iseli C; Stevenson BJ
    PLoS One; 2011 Apr; 6(4):e18369. PubMed ID: 21494657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MAP kinase activity supported by BRAF (V600E) mutation rather than gene amplification is associated with ETV1 expression in melanoma brain metastases.
    Birner P; Berghoff AS; Dinhof C; Pirker C; Capper D; Schoppmann SF; Petzelbauer P; von Deimling A; Berger W; Preusser M
    Arch Dermatol Res; 2014 Dec; 306(10):873-84. PubMed ID: 25073704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastatic lesions with and without interleukin-18-dependent genes in advanced-stage melanoma patients.
    Crende O; Sabatino M; Valcárcel M; Carrascal T; Riestra P; López-Guerrero JA; Nagore E; Mandruzzato S; Wang E; Marincola FM; Vidal-Vanaclocha F
    Am J Pathol; 2013 Jul; 183(1):69-82. PubMed ID: 23707237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.